Catalyst Wire Dossier Catalyst Wire Dossier

Halimatoz

adalimumab · Sandoz GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Halimatoz, covering 2021-01-29 to 2021-01-29. Get the full timeline:

Most recent: EMA Withdrawn: Halimatoz (adalimumab) — Sandoz GmbH

See pricing